Anticancer
| Packaging Type | Vial |
| Country of Origin | Made in India |
| form | Lyophilized Powder |
| Prescription/Non prescription | Prescription |
| injectable form | Injection |
| packing type | Vial |
| use | indicated for treatment of adult patients with multiple myeloma and treatment of adult patients with |
| manufacture | centurion healthcare pvt ltd |
| composition | Each Lyophilized vial containsbortezomib2mg |
| Strength | 3.5 mg |
Bortezomib for Injection is a proteasome inhibitor indicated for treatment of adult patients with multiple myeloma and treatment of adult patients with mantle cell lymphoma.
Additional Information:
- Packaging Details: 2 mg/vial
View Complete Details
| Strength | 50 mg |
| Pack Size | 25 ml |
| Usage/Application | Hospital |
| Pack Type | Vial |
| Compostion | Each ml contains Doxorubicin Hydrochloride USP...2 mg Sodium Chloride USP..................... |
| Manufacturer | centurion healthcare pvt ltd |
| Prescription/Non prescription | Prescription |
| Usages | used successfully to produce regression in disseminated neoplastic conditions |
| Country of Origin | Made in India |
Doxorubicin Hydrochloride Injection, USP has been used successfully to produce regression in disseminated neoplastic conditions such as acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilms' tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, gastric carcinoma, Hodgkin's disease, malignant lymphoma and bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types.
Doxorubicin is also indicated for use as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer.
Additional Information:
- Packaging Details: 1 vial
View Complete Details
| Strength | 50 mg |
| Form | Injection |
| Pack Type | Vial |
| Usage/Application | Hospital |
| Compostion | Each vial contains: Epirubicin Hydrochloride USP..............50mg Lactose Monohydrate........250mg |
| Manufacturer | CENTURION HEALTHCARE PVT LTD |
| Usages | indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involv |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Epirubicin Hydrochloride Injection, USP is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer
Additional Information:
- Packaging Details: 1 VIAL
View Complete Details
Explore more categories
- Developed and Managed by IndiaMART InterMESH Limited
